Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending January 27, 2024 (Week 04) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 56 NC 195 354 New England - NC - 3 Connecticut - NC - - Maine - NC - - Massachusetts - NC - - New Hampshire - NC - 3 Rhode Island - NC - - Vermont - NC - - Middle Atlantic - NC 5 64 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 16 Pennsylvania - NC 5 48 East North Central 46 NC 148 76 Illinois - NC - 1 Indiana - NC 15 21 Michigan - NC - 15 Ohio 46 NC 133 37 Wisconsin - NC - 2 West North Central - NC 5 9 Iowa - NC - 2 Kansas - NC 5 7 Minnesota - NC - - Missouri - NC - - Nebraska - NC - - North Dakota - NC - - South Dakota - NC - - South Atlantic 1 NC 6 46 Delaware - NC - 1 District of Columbia - NC - - Florida N NC N N Georgia - NC - 20 Maryland - NC - - North Carolina - NC - 7 South Carolina - NC - - Virginia - NC - 12 West Virginia 1 NC 6 6 East South Central - NC - 11 Alabama N NC N N Kentucky - NC - - Mississippi - NC - 11 Tennessee - NC - - West South Central - NC - 2 Arkansas - NC - - Louisiana - NC - 2 Oklahoma - NC - - Texas - NC - - Mountain 5 NC 24 47 Arizona 5 NC 24 43 Colorado - NC - - Idaho - NC - - Montana - NC - - Nevada - NC - 2 New Mexico - NC - - Utah - NC - 2 Wyoming - NC - - Pacific 4 NC 7 96 Alaska - NC - - California - NC - 94 Hawaii - NC - - Oregon 4 NC 7 - Washington - NC - 2 U.S. Territories - NC - 10 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 10 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC - - Total 56 NC 195 364 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.